MedPath

The effect of Qishengubiao Granule in asymptomatic patients with Omicron infection: A randomized control trial

Phase 4
Not yet recruiting
Conditions
asymptomatic Omicron patients
Registration Number
ITMCTR2200006009
Lead Sponsor
The First Affiliated Hospital of Nanjing Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.Asymptomatic patients with Omicron infection admitted in Shanghai Lingang Cabin Hospital

Exclusion Criteria

1. Age <14 years old;
2. Pregnant women

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.